methylene blue has been researched along with Brain Vascular Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Holtby, H; Taylor, K | 1 |
| Barthel, H; Burchert, W; Dannenberg, C; Kämpfer, I; Kluge, R; Knapp, WH; Seese, A | 1 |
2 other study(ies) available for methylene blue and Brain Vascular Disorders
| Article | Year |
|---|---|
Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
Topics: Cardiopulmonary Bypass; Cerebrovascular Disorders; Child; Endocarditis, Bacterial; Enzyme Inhibitors; Female; Heart Valve Prosthesis Implantation; Humans; Hypotension; Methylene Blue; Mitral Valve; Shock, Septic; Staphylococcal Infections; Vasoconstrictor Agents | 2005 |
Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Topics: Adult; Aged; Aged, 80 and over; Brain; Cerebrovascular Disorders; Cobalt; Cysteine; Depression; Drug Stability; Female; Humans; Male; Methylene Blue; Middle Aged; Neurodegenerative Diseases; Organotechnetium Compounds; Radiopharmaceuticals; Scalp; Sensitivity and Specificity; Sleep Apnea Syndromes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 1999 |